ibrutinib | Intellepedia

Pharmacyclics Divisional Patent Application Upheld by Calcutta High Court

3D molecular structures illustrating chemical bonding and a detailed fluorinated organic compound model with carbon, hydrogen, oxygen, nitrogen, and fluorine atoms

Calcutta High Court upholds Pharmacyclics divisional patent application for ibrutinib-anti-CD20 therapy, interpreting Section 16 of the Patents Act, 1970.